LQDA Liquidia Corporation
Healthcare$60.09-1.45%ClosedMarket Cap: $5.34B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
49.43
P/S
18.82
EV/EBITDA
103.51
DCF Value
$-98.78
FCF Yield
0.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
91.8%
Operating Margin
15.8%
Net Margin
7.7%
ROE
46.8%
ROA
5.6%
ROIC
12.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $132.9M | 90.9% | $61.5M | $52.9M | $— | — |
| Q4 null | $92.0M | 92.3% | $19.8M | $14.6M | $— | — |
| FY null | $158.3M | 91.6% | $-51.4M | $-68.9M | $— | — |
| Q3 null | $54.3M | 94.2% | $1.8M | $-3.5M | $— | — |
| Q2 null | $8.8M | 85.4% | $-37.5M | $-41.6M | $— | — |
| Q1 null | $3.1M | 51.4% | $-35.4M | $-38.4M | $— | — |
| Q4 null | $2.9M | 53.6% | $-36.1M | $-38.4M | $— | — |
| FY null | $14.0M | 58.0% | $-121.3M | $-130.4M | $— | — |
| Q3 null | $4.4M | 64.8% | $-29.2M | $-23.2M | $— | — |
| Q2 null | $3.7M | 59.2% | $-27.2M | $-27.9M | $— | — |
| Q1 null | $3.0M | 40.9% | $-28.8M | $-40.9M | $— | — |
| Q4 2023 | $4.5M | 78.1% | $-26.4M | $-27.4M | $-0.42 | — |